Ancora Advisors’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63K Hold
24,522
﹤0.01% 2171
2025
Q4
$954 Hold
24,522
﹤0.01% 2238
2025
Q3
$922 Hold
24,522
﹤0.01% 1781
2025
Q2
$866 Hold
24,522
﹤0.01% 1765
2025
Q1
$809 Hold
24,522
﹤0.01% 1606
2024
Q4
$1.15K Hold
24,522
﹤0.01% 1622
2024
Q3
$1.95K Hold
24,522
﹤0.01% 1553
2024
Q2
$1.23K Hold
24,522
﹤0.01% 1634
2024
Q1
$2.61K Hold
24,522
﹤0.01% 1527
2023
Q4
$490 Hold
24,522
﹤0.01% 1604
2023
Q3
$2.08K Sell
24,522
-10
-0% -$1 ﹤0.01% 1487
2023
Q2
$1.15K Hold
24,532
﹤0.01% 1549
2023
Q1
$864 Sell
24,532
-200
-0.8% -$11 ﹤0.01% 1640
2022
Q4
$1K Hold
24,732
﹤0.01% 1664
2022
Q3
$2K Hold
24,732
﹤0.01% 1777
2022
Q2
$3K Hold
24,732
﹤0.01% 1850
2022
Q1
$6K Buy
24,732
+337
+1% +$145 ﹤0.01% 1897
2021
Q4
$19K Hold
24,395
﹤0.01% 1607
2021
Q3
$16K Buy
24,395
+500
+2% +$406 ﹤0.01% 1543
2021
Q2
$22K Buy
+23,895
New +$17K ﹤0.01% 1321

Other funds holding COCHW

Ancora Advisors's COCHW Position: Q1 2026 in Review

Ancora Advisors held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 24,522 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Ancora Advisors first reported a position in COCHW in Q2 2021 and has held it in 20 quarters since. The position peaked at $22K in Q2 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Ancora Advisors held 24,522 shares of Envoy Medical Warrant worth $1.63K as of Q1 2026.
  • Ancora Advisors left its Envoy Medical Warrant share count unchanged in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #2171 holding.
  • Ancora Advisors first reported a position in Envoy Medical Warrant in Q2 2021 and has held it in 20 quarters since.
  • Ancora Advisors's Envoy Medical Warrant position peaked at $22K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.